Mandrake Bio: Valuation, Funding & Investors
Mandrake Bio harnesses the intersection of AI and structural biology to design and engineer de novo proteins at scale. The company develops computational and experimental platforms to accelerate protein discovery and design for applications across therapeutics, industrial biotechnology, and sustainability.
Leadership & Board
Key Executives
- CEO
- Tanay Lohia
- Founder
- Kutubuddin Molla
- Current Number of Employees
- 12
- Current LinkedIn Followers
- 5,640
Latest Estimated Valuation
- Total Amount Raised
- $2M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $2M
- Latest Funding Round
- Pre-Seed
Company Momentum
PositiveMandrake Bio LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Mandrake Bio had 12 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Mandrake Bio had 5,640 followers as of November 2, 2026. The number of followers increased by 18 (0.32%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jul 21, 2026 | Pre-Seed | $1.66M | ― |
Similar Companies
A snapshot of private companies similar to Mandrake Bio, helping you discover and navigate related company profiles.
Related News and Analysis
